SEAN DITTMAN: Open Payments
NPI 1043676307 · GARDEN RIDGE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 28 payments from 11 companies in 2025. Trend: 2023 $1,031 · 2024 $1,513 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $100 |
| Lilly USA, LLC | 4 | $85 |
| Novo Nordisk Inc | 4 | $67 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| PFIZER INC. | 3 | $57 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| Dexcom, Inc. | 2 | $33 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Krystal Biotech Inc | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $16 |
Products named: MOUNJARO, VRAYLAR, KEVEYIS, QULIPTA, NURTEC ODT, Ozempic, Dexcom G6 Transmitter, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
